Vaxil Bio Ltd.

C$0.11As of Sun 8 Nov 2026, 12:00 UTC
TSXV:VXLHealthcare
Country Canada
PE (Fwd) •••
TSR 10Y CAGR (34.16%)
Div yield —
ROE 39.89%
Biotechnology
Beta (5Y) (0.19)
PE TTM 1.003
TSR TTM (38.89%)
Mkt cap C$0.438M
ROIC (16.91%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.112
1.39%
(77.21%)
Hold 2|1|7|3|6
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
19.75%
29.29%
23.13%
9.27%
Revenue$M
0.028
0.028
0.028
0.028
5.70%
5.95%
2.15%
3.33%
Peers (US$0.310M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.749
(0.187)
(0.124)
EBIT/Intx
2.648
0.181
0.185
Own earn%
14.64
(168.63)
(160.01)
Sh yield%
13.55
61.96
62.18
Owners
Insiders/Inst%
3.25
87.62
Short interest%
4.66
SBC / revenue%
3.83
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
9–15
$1 testx
−0.2
Incr. ROIC%
17